Media Coverage

A New Era of Collaboration Promises to Deliver More Value for Patients
2nd January 2023
Companies pursuing interventions to edit, regenerate and reprogram eye tissue to restore lost vision.
7th October 2022
Mogrify and Astellas to address hearing loss
8th September 2022
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
22nd July 2022
The Innovation Awards 2021 - the best drug development and manufacturing technologies of 2021
16th December 2021
New Biotherapies Push Technological Innovation Forward
3rd June 2021
A UK-based startup looks to beat Spark's Luxturna at its own game with programmable cell platform for eye disease
4th May 2021
Following in-depth therapeutic review, Mogrify adds $17M to series A
4th May 2021
Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
5th January 2021
The True (If Circuitous) Path to Stem Cell Cures
27th November 2020
Mogrify scoops innovation award
22nd September 2020
Mogrify announces the appointment of Lorenz Mayr
9th September 2020
Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019
5th December 2019
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
14th October 2019
Mogrify appoints Dr. Jane Osbourn, OBE as Chair
9th September 2019
Mogrify strengthens team and relocates to the Bio-Innovation Centre, TusPark Cambridge
20th May 2019
Big data-science for cell therapies: Mogrify boosted by $3.7m funding
21st February 2019
Darrin Disley takes CEO role at cell therapy startup
20th February 2019